Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16890670

Download in:

View as

General Info

PMID
16890670